APA

van den Bos W., de Bruin D. M., Muller B. G., Varkarakis I. M., Karagiannis A. A., Zondervan P. J., Laguna Pes M. P., Veelo D. P., Savci Heijink C. D., Engelbrecht M. R. W., Wijkstra H., de Reijke T. M. & de la Rosette J. J. M. C. H. (20150630). The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. : BMJ open.

Chicago

van den Bos W, de Bruin D M, Muller B G, Varkarakis I M, Karagiannis A A, Zondervan P J, Laguna Pes M P, Veelo D P, Savci Heijink C D, Engelbrecht M R W, Wijkstra H, de Reijke T M and de la Rosette J J M C H. 20150630. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. : BMJ open.

Harvard

van den Bos W., de Bruin D. M., Muller B. G., Varkarakis I. M., Karagiannis A. A., Zondervan P. J., Laguna Pes M. P., Veelo D. P., Savci Heijink C. D., Engelbrecht M. R. W., Wijkstra H., de Reijke T. M. and de la Rosette J. J. M. C. H. (20150630). The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. : BMJ open.

MLA

van den Bos W, de Bruin D M, Muller B G, Varkarakis I M, Karagiannis A A, Zondervan P J, Laguna Pes M P, Veelo D P, Savci Heijink C D, Engelbrecht M R W, Wijkstra H, de Reijke T M and de la Rosette J J M C H. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. : BMJ open. 20150630.